However, while our case was found to be positive for MLH1 and MSH2 expression, we lack information regarding MSI status because, at our center, this analysis is routinely performed only for adenocarcinomas and squamous cell carcinomas, rather than for sarcomas. The gene discussed is MSH2; the disease is squamous cell carcinoma.